Author Question: Patients with sickle cell disease suffer from vaso-occlusive crises because: a. The altered ... (Read 65 times)

maychende

  • Hero Member
  • *****
  • Posts: 556
Patients with sickle cell disease suffer from vaso-occlusive crises because:
 
  a. The altered hemoglobin facilitates the formation of bar-shaped hemoglobin crystals that occlude blood vessels.
  b. The altered hemoglobin impairs the hemoglobin's ability to effectively transport oxygen that causes vaso-occlusion.
  c. The altered hemoglobin facilitates tactoid crystal formation that alters the shape of the red blood cell, resulting in impeded blood flow in vessels.
  d. The altered hemoglobin interferes with globin chain assembly, which impedes blood flow in the vessels.

Question 2

Hemoglobin C disease has altered solubility properties similar to hemoglobin S disease. What accounts for this altered solubility?
 
  a. Heme iron is in the ferric form rather than ferrous form.
  b. The hemoglobin remains in the tense structure.
  c. A nonpolar amino acid is substituted for a polar amino acid.
  d. A polar amino acid is substituted near the pocket where heme binds.



Gabe

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Correct Answer: C

Answer to Question 2

Correct Answer: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library